0001638599-18-000721.txt : 20180703 0001638599-18-000721.hdr.sgml : 20180703 20180703141404 ACCESSION NUMBER: 0001638599-18-000721 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180702 FILED AS OF DATE: 20180703 DATE AS OF CHANGE: 20180703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rowe Michael M CENTRAL INDEX KEY: 0001744774 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38365 FILM NUMBER: 18936160 MAIL ADDRESS: STREET 1: C/O EYENOVIA, INC. STREET 2: 501 FIFTH AVENUE, SUITE 1404 CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EYENOVIA, INC. CENTRAL INDEX KEY: 0001682639 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 471178401 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8748 TECHNOLOGY WAY CITY: RENO STATE: NV ZIP: 89521 BUSINESS PHONE: 813-766-9539 MAIL ADDRESS: STREET 1: 8748 TECHNOLOGY WAY CITY: RENO STATE: NV ZIP: 89521 4 1 doc4_5497.xml PRIMARY DOCUMENT X0306 4 2018-07-02 0 0001682639 EYENOVIA, INC. EYEN 0001744774 Rowe Michael M C/O EYENOVIA, INC. 501 FIFTH AVENUE, SUITE 1404 NEW YORK NY 10017 0 1 0 0 Vice President of Marketing Common Stock, par value $.0001 200 D Stock Option (right to buy) 6.30 2018-07-02 4 A 0 60000 0.00 A 2028-07-02 Common Stock 60000 60000 D The option becomes exercisable as to 1,666 shares on August 2, 2018, and becomes exercisable in equal 1,666 share amounts on each of the 35 one-month anniversaries thereafter. /s/ S. Halle Vakani, Attorney-in-Fact 2018-07-03